Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6

Increasing evidence implicates apoptosis as a major mechanism of cell death in methamphetamine (METH) neurotoxicity. The involvement of a neuroimmune component in apoptotic cell death after injury or chemical damage suggests that cytokines may play a role in METH effects. In the present study, we ex amined if the absence of IL-6 in knockout (IL-6-/-) mice could provide prot ection against METH-induced neurotoxicity. Administration of METH resulted in a significant reduction of [I-125] RTI-121-labeled dopamine transporters in the caudate-putamen (CPu) and cortex as well as depletion of dopamine i n the CPu and frontal cortex of wild-type mice. However, these METH-induced effects were significantly attenuated in IL-6-/- animals. METH also caused a decrease in serotonin levels in the CPu and hippocampus of wild-type mic e, but no reduction was observed in IL-6-/- animals. Moreover, METH induced decreases in [I-125]RTI-55-labeled serotonin transporters in the hippocamp al CA3 region and in the substantia nigra-reticulata but increases in serot onin transporters in the CPu and cingulate cortex in wild-type animals, all of which were attenuated in IL-6-/- mice. Additionally, METH caused increa sed gliosis in the CPu and cortices of wild-type mice as measured by [H-3] PK-11195 binding; this gliotic response was almost completely inhibited in IL-6-/- animals. There was also significant protection against METH-induced DNA fragmentation, measured by the number of terminal deoxynucleotidyl tra nsferase-mediated dUTP nick-end-labeled (TUNEL) cells in the cortices. The protective effects against METH toxicity observed in the IL-6-/- mice were not caused by differences in temperature elevation or in METH accumulation in wild-type and mutant animals. Therefore, these observations support the proposition that IL-6 may play an important role in the neurotoxicity of ME TH.